Acetic Acid

Acetic Acid

SCHEMBL1157575

CC(=O)O.O=C(Nc1ccccc1-c1ccccc1)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 16/20 0.58
CHRM2 P08172 2/20 0.58
CHRM1 P11229 2/20 0.58
EPHX2 P34913 1/20 0.54
KMT2A Q03164 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL1157085 0.85 EPHX2 (0.60) EPHX2KMT2A
SCHEMBL1157555 0.83 EPHX2 (0.53) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL119223 0.82 EPHX2 (0.60) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL9588677 0.82 EPHX2 (0.56) CHRM3EPHX2KMT2A
SCHEMBL29913938 0.82 EPHX2 (0.60) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL29401765 0.82 EPHX2 (0.60) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL29067330 0.80 EPHX2 (0.57) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL3234085 0.80 KMT2A (0.58) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL1157557 0.80 EPHX2 (0.55) CHRM3CHRM2CHRM1EPHX2KMT2A
SCHEMBL25307975 0.80 EPHX2 (0.54) CHRM3CHRM2CHRM1EPHX2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110039714-A1 Probes, Systems, and Methods for Drug Discovery VTVX HOLDINGS I LLC 2011-02-17 US disclosed
EP-1383799-A1 PROBES, SYSTEMS AND METHODS FOR DRUG DISCOVERY TransTech Pharma Inc. (US) 2004-01-28 EP disclosed
WO-2003084997-A1 PROBES, SYSTEMS AND METHODS FOR DRUG DISCOVERY TRANSTECH PHARMA, INC. (US) 2003-10-16 WO disclosed
US-20030125315-A1 Probes, systems, and methods for drug discovery TRANSTECH PHARMA, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125315-A1 Probes, systems, and methods for drug discovery ABCG2, EZR, PAICS CHRM3 1528/4885CHRM2 3854/4885CHRM1 3983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.